High-Performance Liquid Chromatography Market: By Type, Drivers, Industry Analysis, Segments And Forecast To 2033

The high-performance liquid chromatography market size has grown strongly in recent years. It will grow from $5.84 billion in 2023 to $6.32 billion in 2024 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increase in pharmaceutical research, rise in food and beverage analysis, rise in demand from environmental testing, increase in increased use in clinical diagnostics, rise in research and development.

The high-performance liquid chromatography market size is expected to see rapid growth in the next few years. It will grow to $9.3 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing drug safety and quality assurance, demand from precision medicine, expansion of increasing environmental monitoring, increasing method development. Major trends in the forecast period include advanced detectors, high-throughput hplc, green and sustainable hplc, uhplc adoption, lc-ms integration.

Market Overview -
High-performance liquid chromatography (HPLC) is a technique for separating the components of a mixture and identifying and quantifying each component. The HPLC is utilized in the quantitative determination of plasma levels of drugs and their metabolites. This is especially crucial for the creation of novel medications and for the supervision of therapy.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=8975&type=smp

The Surge In Chronic Disease Prevalence Fuels Growth Of The High-Performance Liquid Chromatography Market
An increase in the prevalence of chronic diseases is expected to propel the growth of the high-performance liquid chromatography market going forward. Chronic diseases such as cancer, heart disease, stroke, diabetes, and arthritis are diseases that often last for a longer time and require more medical attention. High-performance liquid chromatography (HPLC) analyzes any medications in order to validate their identity, provide quantitative data, and track the progress of illness therapy. It may also be utilized to advance the understanding of normal and pathological processes in the human body through biological and therapeutic research prior to medication licensing which in turn is boosting the growth of the market. For instance, in 2021, according to the Chronic Disease Burden Report 2021, published by the Pennsylvania Department of Health, a US-based government institution in charge of administering and regulating healthcare services, every year, over 659,000 Americans die as a result of heart disease, accounting for roughly one-quarter of all deaths in the country. Medical costs for heart disease and stroke are estimated to be around $200 billion per year, with lost productivity on the job costing around $131 billion. Cancer is the second largest cause of death in the United States, after heart disease. Every year, around 1.6 million individuals are diagnosed with cancer, and 600,000 people die from it. Cancer care costs are projected to exceed $245 billion by 2030 . Therefore, the increase in the prevalence of chronic diseases is driving the growth of the high-performance liquid chromatography market.

Competitive Landscape -
Major companies operating in the high-performance liquid chromatography market include Waters Corporation, Agilent Technologies Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., GE Healthcare, Bio-Rad Laboratories Inc., Merck Millipore, Hitachi Ltd., Phenomenex Inc., JASCO Corporation, Gilson Inc., Knauer GmbH, SIELC Technologies, Tosoh Bioscience LLC, YMC Co. Ltd., GL Sciences Inc., Sepax Technologies Inc., Restek Corporation, Hamilton Company, ACE HPLC Columns, Advanced Chromatography Technologies Ltd., Alltech Associates Inc., Analytical Sales and Services Inc., Chromatography Research Supplies Inc., Daicel Corporation, Eksigent Technologies LLC, W. R. Grace & Co., Hichrom Limited

Technological Advancements Drive Innovation In The High-Performance Liquid Chromatography Market
Technological advancements are the key trend gaining popularity in the high-performance liquid chromatography market. Major companies operating in the market are developing advanced HPLC technologies such as integrated high-performance liquid chromatography (HPLC) and ultra-high performance liquid chromatography (UHPLC) capabilities, as well as other HPLC systems that provide dual-injection systems, multidimensional capabilities, and intermediate pressure alternatives, increasing the technique's utility for a wide range of research applications. For instance, in July 2021, Trivitron Healthcare, an India-based medical technology company, launched two new HPLC-based solutions for HbA1c and Hb variant detection, the NANO H5 and the NANO H110. These products are designed to provide accurate and timely results for monitoring diabetes, thalassemia, and hemoglobin variants. The NANO H5 is a compact and automated HPLC analyzer that can process five samples at a time, with a processing time of 130 seconds. The NANO H110 is also a compact and automated HPLC analyzer, but it has a dual test mode for HbA1c and Hb variant detection and a higher sample loading capacity of 110 samples at a time.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/high-performance-liquid-chromatography-global-market-report

Key Segments -
The high-performance liquid chromatography market covered in this report is segmented -
1) By Product: Instruments, Consumables, Accessories
2) By Application: Clinical Research, Diagnostics, Forensic, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Industries, Diagnostic Laboratories, Food And Beverage Industry, Academic And Research Institutes, Others End-Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.